| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.073 | 0.01 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |